Page last updated: 2024-09-05

erlotinib hydrochloride and Gastric Ulcer

erlotinib hydrochloride has been researched along with Gastric Ulcer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bradbury, PA; Hilton, JF; Seymour, L; Shepherd, FA; Tu, D1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Gastric Ulcer

ArticleYear
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.
    Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:1

    Topics: Anti-Ulcer Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinazolines; Randomized Controlled Trials as Topic; Ranitidine; Retrospective Studies; Stomach Ulcer; Treatment Outcome

2013